Decline in frequency of DD genotype in hypertensive patients with age

published_or_final_versio

Angiotensin-converting enzyme genotypes in hypertensive patients with left ventricular hypertrophy

published_or_final_versio

Angiotensinogen gene and hypertension in Chinese

published_or_final_versio

Family history of hypertension is related to angiotensin-converting enzyme genotype

published_or_final_versio

Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008

PURPOSE: The prevalence of obesity has been increasing in the United States. We set out to investigate the use of pharmacologic and non-pharmacologic therapy for the treatment of obesity in recent years. METHODS: We included 2630 men and 2702 women who took part in the National Health and Nutrition Examination Survey from 2007 to 2008. We analyzed their demographic and anthropometric data and their weight and drug history. RESULTS: A total of 45.9% of men and 45.0% of women were candidates for treatment (body mass index >/=30 kg/m(2), or >/=27 kg/m(2) with risk factors). Among these participants, 85.1% considered themselves overweight, 90.1% would like to lose weight, 61.9% had dietary changes, 36.5% exercised, 3.7% took nonprescription drugs, and 2.2% took prescription drugs to control weight during the preceding year. During the preceding month, 0.5% and 0.1% of participants were taking phentermine and orlistat, respectively. There were no participants on sibutramine. CONCLUSIONS: Although obesity is highly prevalent, only a small percentage of obese Americans are on anti-obesity medication. The withdrawal of sibutramine would have minimal impact on the general population. There is a need for more lifestyle changes in the majority of obese individuals.published_or_final_versio

Pharmacological management of obesity in the National Health and Nutrition Examination Survey (NHANES) 2007-8

Poster Session II: Translational & Clinical: Clinical Pharmacologypublished_or_final_versionThe 16th Medical Research Conference, Department of Medicine, The University of Hong Kong, Hong Kong, 22 January 2011. In Hong Kong Medical Journal, 2011, v. 17 n. 1, Suppl. 1, p. 50, abstract no. 8

Plasma level of adrenomedullin is elevated in systemic lupus erythematosis

published_or_final_versio

Plasma adrenomedullin level is markedly elevated in bronchiectasis

published_or_final_versio

HpaII polymorphism in the atrial natriuretic peptide gene in patients with essential hypertension

published_or_final_versio

Plasma adrenomedullin level in patients with heart failure is related to systolic but not diastolic dysfunction

published_or_final_versio